HealthSouth Corporation (NYSE:HLS) – Equities researchers at KeyCorp lowered their Q4 2017 earnings per share (EPS) estimates for HealthSouth Corporation in a research report issued on Friday. KeyCorp analyst J. Gurda now expects that the company will post earnings per share of $0.64 for the quarter, down from their prior forecast of $0.65. KeyCorp has a “Hold” rating on the stock.

HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. HealthSouth Corporation had a net margin of 6.69% and a return on equity of 22.81%. The company had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. During the same period last year, the company earned $0.65 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year.

WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/10/30/healthsouth-corporation-to-post-q4-2017-earnings-of-0-64-per-share-keycorp-forecasts-hls.html.

HLS has been the topic of several other research reports. Stephens began coverage on HealthSouth Corporation in a report on Thursday, August 31st. They set an “overweight” rating and a $53.00 price objective on the stock. Zacks Investment Research upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Royal Bank Of Canada restated a “buy” rating and set a $55.00 price objective on shares of HealthSouth Corporation in a report on Wednesday, September 6th. ValuEngine upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 7th. Finally, BidaskClub downgraded HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $50.38.

Shares of HealthSouth Corporation (NYSE:HLS) opened at 46.03 on Monday. The firm’s 50 day moving average is $45.36 and its 200 day moving average is $45.57. The firm has a market capitalization of $4.54 billion, a PE ratio of 16.77 and a beta of 0.58. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71.

Several hedge funds and other institutional investors have recently made changes to their positions in HLS. Mackay Shields LLC bought a new stake in shares of HealthSouth Corporation in the 2nd quarter valued at approximately $39,641,000. TimesSquare Capital Management LLC bought a new stake in shares of HealthSouth Corporation in the 2nd quarter valued at approximately $37,868,000. APG Asset Management N.V. bought a new stake in shares of HealthSouth Corporation in the 3rd quarter valued at approximately $27,082,000. William Blair Investment Management LLC grew its stake in shares of HealthSouth Corporation by 13.9% in the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after buying an additional 525,767 shares in the last quarter. Finally, Balyasny Asset Management LLC grew its stake in shares of HealthSouth Corporation by 421.4% in the 2nd quarter. Balyasny Asset Management LLC now owns 618,311 shares of the company’s stock valued at $29,926,000 after buying an additional 499,715 shares in the last quarter. 93.11% of the stock is owned by institutional investors and hedge funds.

In related news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the completion of the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.60% of the company’s stock.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 annualized dividend and a yield of 2.17%. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 36.36%.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Earnings History and Estimates for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.